[Therapeutic update 1997-1998 (1). First part].
The most important drugs registered and/or launched in Belgium during the last year in the various disciplines of internal medicine will be briefly described. The originality of each molecule as well as its modalities of appropriate use in clinical practice will be stressed. This first part is devoted to drugs acting on cardiovascular, respiratory, digestive and neurologic diseases.
Scheen
A J
AJ
Département de Médecine, Université de Liège.
D001530:Belgium; D001682:Biological Availability; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004358:Drug Therapy / Q000639:trends*; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D009422:Nervous System Diseases / Q000188:drug therapy*; D004364:Pharmaceutical Preparations / Q000600:supply & distribution; D012140:Respiratory Tract Diseases / Q000188:drug therapy*
D004364:Pharmaceutical Preparations